Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th AccessWire - Tue Apr 26, 2022

NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders,...

PTIX : 1.4100 (+1.81%)
Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update Globe Newswire - Tue Nov 16, 2021

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET Globe NewsWire - Mon Aug 30, 2021

Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and A ddiction to be discussed

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update Globe NewsWire - Tue Aug 17, 2021

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial Globe NewsWire - Fri Jul 23, 2021

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 AccessWire - Thu Jul 8, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

ACER : 0.6601 (-17.95%)
ADXN : 7.54 (-53.17%)
AGRX : 0.4297 (+7.43%)
ACOG.VN : 0.240 (unch)
ATGN : 0.7470 (-5.44%)
ABIO : 3.43 (-4.19%)
AUUD : 1.6500 (-6.78%)
BASA : 0.0116 (+10.48%)
BMRA : 0.5325 (-19.95%)
BKTI : 13.98 (-1.18%)
BSFC : 0.0585 (-7.87%)
DTST : 4.99 (-2.73%)
Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET Globe NewsWire - Tue Jul 6, 2021

NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 AccessWire - Wed Jun 23, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

ACER : 0.6601 (-17.95%)
ADXN : 7.54 (-53.17%)
AGRX : 0.4297 (+7.43%)
ACOG.VN : 0.240 (unch)
ATGN : 0.7470 (-5.44%)
ABIO : 3.43 (-4.19%)
AUUD : 1.6500 (-6.78%)
BASA : 0.0116 (+10.48%)
BKTI : 13.98 (-1.18%)
BSFC : 0.0585 (-7.87%)
DTST : 4.99 (-2.73%)
DCTH : 5.21 (-1.70%)
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th Globe NewsWire - Wed Jun 16, 2021

NEW YORK , June 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders,...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)
Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq Globe NewsWire - Thu Apr 29, 2021

New York, April 29, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the closing of an underwritten public offering of 3,180,000 units at a...

PTIXW : 0.0198 (-12.00%)
PTIX : 1.4100 (+1.81%)

Barchart Exclusives

Here's Why Novo Nordisk Stock Is a Buy Right Now Barchart - 5 minutes ago
Novo Nordisk stock has surged, outperforming the market this year. Here's why it still looks like a buy right now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot